[New SBU-report on estrogen replacement therapy in climacteric. Moderate risk of breast cancer after long-term use].
In 1966 the Swedish Council on Technology Assessment in Health Care (SBU) published a scientific review of estrogen treatment following menopause. A new report by SBU has now reviewed, classified and graded the scientific literature on hormone replacement therapy 1995-2001. In some cases the scientific evidence has become stronger (risk for breast cancer after long-term treatment) while in other cases the uncertainty identified in the earlier report remains (effect on cardiovascular disease and stroke).
D001943:Breast Neoplasms / Q000139:chemically induced*; D002979:Climacteric; D015914:Estrogen Replacement Therapy / Q000009:adverse effects*; D005260:Female; D020249:Hormone Replacement Therapy / Q000009:adverse effects; D006801:Humans; D008593:Menopause; D008875:Middle Aged; D011372:Progestins / Q000009:adverse effects; D012307:Risk Factors; D013997:Time Factors
D011372:Progestins